Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.